10x Genomics (TXG) Free Cash Flow Growth (3y) (2021 - 2026)
10x Genomics (TXG) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 30.79% |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 47.95% |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 53.56% |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | - |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 32.96% |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 40.06% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -54.61% |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 54.31% |
| 10 | Teladoc Health | 1.31 Bn | 562.23 Mn | 562.57 Mn | 6.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.06% |
| Dec 31, 2025 | 34.63% |
| Sep 30, 2025 | 37.10% |
| Jun 30, 2025 | 31.65% |
| Mar 31, 2025 | 42.70% |
| Dec 31, 2024 | -31.83% |
| Sep 30, 2024 | 31.74% |
| Jun 30, 2024 | 62.40% |
| Mar 31, 2024 | -36.71% |
| Dec 31, 2023 | 30.35% |
| Sep 30, 2023 | 26.63% |
| Jun 30, 2023 | 36.22% |
| Mar 31, 2023 | -86.23% |
| Dec 31, 2022 | -44.25% |
| Sep 30, 2022 | -2.30% |
| Jun 30, 2022 | -189.31% |
| Mar 31, 2022 | -99.03% |
| Dec 31, 2021 | 48.36% |